Last reviewed · How we verify
RNTCP Category I treatment for 9months
RNTCP Category I treatment for 9months is a Antitubercular Small molecule drug developed by All India Institute of Medical Sciences. It is currently in Phase 3 development for Pulmonary tuberculosis, Extrapulmonary tuberculosis.
Isoniazid is a prodrug that is converted to its active form, which inhibits the synthesis of mycolic acid in Mycobacterium tuberculosis.
Isoniazid is a prodrug that is converted to its active form, which inhibits the synthesis of mycolic acid in Mycobacterium tuberculosis. Used for Pulmonary tuberculosis, Extrapulmonary tuberculosis.
At a glance
| Generic name | RNTCP Category I treatment for 9months |
|---|---|
| Sponsor | All India Institute of Medical Sciences |
| Drug class | Antitubercular |
| Target | InhA (Isoniazid target) |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
This inhibition disrupts the cell wall formation of the bacteria, ultimately leading to cell death. Isoniazid is a key component of the RNTCP Category I treatment regimen for tuberculosis.
Approved indications
- Pulmonary tuberculosis
- Extrapulmonary tuberculosis
Common side effects
- Peripheral neuropathy
- Hepatitis
- Rash
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RNTCP Category I treatment for 9months CI brief — competitive landscape report
- RNTCP Category I treatment for 9months updates RSS · CI watch RSS
- All India Institute of Medical Sciences portfolio CI
Frequently asked questions about RNTCP Category I treatment for 9months
What is RNTCP Category I treatment for 9months?
How does RNTCP Category I treatment for 9months work?
What is RNTCP Category I treatment for 9months used for?
Who makes RNTCP Category I treatment for 9months?
What drug class is RNTCP Category I treatment for 9months in?
What development phase is RNTCP Category I treatment for 9months in?
What are the side effects of RNTCP Category I treatment for 9months?
What does RNTCP Category I treatment for 9months target?
Related
- Drug class: All Antitubercular drugs
- Target: All drugs targeting InhA (Isoniazid target)
- Manufacturer: All India Institute of Medical Sciences — full pipeline
- Therapeutic area: All drugs in Infectious Diseases
- Indication: Drugs for Pulmonary tuberculosis
- Indication: Drugs for Extrapulmonary tuberculosis
- Compare: RNTCP Category I treatment for 9months vs similar drugs
- Pricing: RNTCP Category I treatment for 9months cost, discount & access